Journals / Laparoscopic Endoscopic Surgical Science / 2021 / Cilt: 28 - Sayı: 4

Evaluation of the effectiveness of using two different probiotics in helicobacter eradication treatment

Pages
176–181
Publication Date
2022-09-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Combined use of probiotic increases helicobacter eradication in addition to reducing the side effects of antibiotics due to H. pylori.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: We aimed to evaluate the effects of the addition of probiotics containing Lactobacillus acidophilus + Bifidobacterium animalis Subsp lactis to the classic triple treatment protocol (lansoprozole + amoxycillin + clarithromycin) on the success of Helicobacter pylori eradication and antibiotic side effects.
📊
Key Findings & Data:Patients in both groups were treated for 14 days.
💡
Conclusion & Impact:Conclusion: Combined use of probiotic increases helicobacter eradication in addition to reducing the side effects of antibiotics due to H. pylori.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: We aimed to evaluate the effects of the addition of probiotics containing Lactobacillus acidophilus + Bifidobacterium animalis Subsp lactis to the classic triple treatment protocol (lansoprozole + amoxycillin + clarithromycin) on the success of Helicobacter pylori eradication and antibiotic side effects. Materials and Methods: Standard therapy (lansoprozole + amoxycillin + clarithromycin), and probiotics containing in addition to standard therapy were determined. Patients in both groups were treated for 14 days. The prebiotic, containing two different strains, was in capsule form and used twice a day. We demonstrated the helicobacter eradication status by looking at the helicobacter antigen from the stool. Statistical analyzes between the two groups were made using the pearson Chi-square test. P<0.05 was accepted as the significance level. Results: The rate of discontinuing treatment due to side effects was 15.3% in group 1, this rate was 4.5% in group 2. When double probiotics were added to the treatment, it was observed that there was a decrease of 11.2% in serious side effects (p<0.001). After the completion of the treatments. It was observed that helicobacter eradication was achieved in 152 out of 222 patients (68%) in group 1 and in 214 (89%) of 240 patients in group 2. When double probiotics were added to the treatment, it was observed that the success of eradication increased by 21% (p<0.001). Conclusion: Combined use of probiotic increases helicobacter eradication in addition to reducing the side effects of antibiotics due to H. pylori.

🔖

Cite This Article

YÜRÜKER, S. S., YILDIRIM, M., UĞURLU, C., KOCA, B., BOSTAN, M. S., ÖZKAN, N., KILIÇ, E. (2022). Evaluation of the effectiveness of using two different probiotics in helicobacter eradication treatment. Laparoscopic Endoscopic Surgical Science, Cilt: 28 - Sayı: 4, 176–181. https://ajindex.com/articles/423545

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017;153:420–9
  2. Sjökvist Ottsjö L, Jeverstam F, Yrlid L, Wenzel AU, Walduck AK, Raghavan S. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization. Immunology 2017;150:172–83
  3. Bagheri N, Azadegan-Dehkordi F, Rafieian-Kopaei M, Rahimian G, Asadi-Samani M, Shirzad H. Clinical relevance of Helicobacter pylori virulence factors in Iranian patients with gastrointestinal diseases. Microb Pathog 2016;100:154–62
  4. Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 2017;153:420–9
  5. O’Connor A, O’Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 2017;14:230–40
  6. Malfertheiner P, Megraud F, O’Morain AC. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017;66:6–30
  7. Asgari B, Kermanian F, Derakhshan N, Asna-Ashari M, Sadat ZRN, Yaslianifard S. Honey-derived Lactobacillus rhamnosus alleviates Helicobacter pylori-induced gastro-intestinal infection and gastric inflammation in C57BL/6 mice: an immuno- histologic study. Arq Gastroenterol 2018;55:279–82
  8. Talebi Bezmin Abadi A. Probiotics as Anti-Helicobacterpylori Agent: State of the Art. Anti Infect Agents 2017;15:63–8
  9. Evans JD, Lopez DL. Bacterial probiotics induce an immune response in the honey bee (Hymenoptera: Apidae). J Econ Entomol 2004;97:752–6
  10. Mousavi S, Dehkordi FS, Rahimi E. Virulence factors and antibiotic resistance of Helicobacter pylori isolated from raw milk and unpasteurized dairy products in Iran. J Venom Anim ToxinsIncl Trop Dis 2014;20:51
  11. Yahaghi E, Khamesipour F, Mashayekhi F, Safarpoor Dehkordi F, Sakhaei MH, Masoudimanesh M, et al. Helicobacter pylori in vegetables and salads: genotyping and antimicrobial resistance properties. Biomed Res Int 2014;2014:757941
  12. Tuccori M, Lapi F, Testi A, Ruggiero E, Moretti U, Vannacci A, et al. Drug-induced taste and smell alterations: a case/ non-case evaluation of an italian database of spontaneous adverse drug reaction reporting. Drug Saf 2011;34:849–59
  13. Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the